{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-109133","form_type":"8-K","ticker":"RZLT","cik":"0001509261","company_name":"Rezolute, Inc.","filed_at":"2023-10-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.308809+00:00","generated_at":"2026-06-09T23:59:13.671918+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Rezolute reports RZ358 resolves hypoglycemia in tumor-mediated hyperinsulinism patient","bullets":["RZ358 administered on compassionate-use basis to patient with refractory hypoglycemia due to metastatic insulin-secreting cervical cancer.","Treatment started September 2023; resulted in resolution of hypoglycemia and enabled hospital discharge to resume cancer therapy.","Prior metastatic insulinoma patient has remained on RZ358 for nearly a year; case published in NEJM (389;8).","Company sees RZ358 as potential universal treatment for hyperinsulinism; evaluating next steps in additional indications."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-109133","json":"https://secwatch.observer/filing/0001104659-23-109133.json","markdown":"https://secwatch.observer/filing/0001104659-23-109133.md","text":"https://secwatch.observer/filing/0001104659-23-109133.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1509261/000110465923109133/0001104659-23-109133-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1509261/000110465923109133/tm2328296d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T23:59:13.671918+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}